Novartis has another phase 3 trial win in its quiver for targeted factor B inhibitor iptacopan, building the case for the drug as a new oral therapy for diseases caused by disorders of the complement ...

A few short years ago, major crossbow brands like Ravin and TenPoint were in a race to break the 500-feet-per-second mark, and both were successful. I tested and hunted extensively with such ...

I have killed five bears above the black-bear class with a bow in the last six years and tackled two others that proved too much to handle that way and had to be stopped with a rifle. From those seven ...

Here's a phrase to describe someone who overreacts easily ...

Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...